Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The 5-grass pollen tablet (Oralair®, Stallergenes, Antony, France) is a once-daily preseasonal and coseasonal sublingual immunotherapy (SLIT) that is effective in controlling the symptoms of allergic rhinoconjunctivitis and in reducing the need for symptomatic medication.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Expert Opin Drug Saf

Title: Expert opinion on drug safety

ISSN (Electronic): 1744-764X

ISSN (Print): 1474-0338

Publication date (Electronic): May 2015

Volume: 14

Issue: 5

Affiliations

[1 ] Rangueil-Larrey Hospital, Respiratory Diseases Department , 24 Chemin de Pouvourville - TSA 30030, 31059 Toulouse Cedex 9 , France +33 05 6777 1850; +33 05 6777 1472; didier.a@chu-toulouse.fr.

Article

DOI: 10.1517/14740338.2015.1017468

PubMed ID: 25732009

SO-VID: 847a95fb-3773-4ad3-b0c9-a8df44ae5104

History

Keywords: 5-grass pollen tablet,allergic rhinitis,allergic rhinoconjunctivitis,asthma,clinical trial,pollinosis,safety,sensitization,sublingual immunotherapy,tolerability

Data availability:

Keywords: 5-grass pollen tablet, allergic rhinitis, allergic rhinoconjunctivitis, asthma, clinical trial, pollinosis, safety, sensitization, sublingual immunotherapy, tolerability

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 13

See all cited by